The U.S. patent validates a biological approach to degrading glyphosate as pressure grows around herbicide safety and ...
On this episode of Understanding IP Matters, Allison Gaul discusses the aggressive landscape of data acquisition by various AI entities.
Amgen Inc. is at least fairly valued, with improving balance sheet metrics and a robust growth pipeline offsetting looming ...
The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...
Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...
Outlook Business on MSN
After Dr Reddy’s, Sun Pharma Gets Court Nod to Export Weight-Loss Drug
The order followed the company’s assurance that it would not market any anti-obesity products in India until the patent lapses. The court had granted similar relief to Dr Reddy’s Laboratories earlier ...
Cuts to federally funded research and patents will keep lifesaving products away from the public and cost jobs and revenue.
Sometimes we take things we have around for granted. Basically, we assume that this one useful thing we always have available will be like this whenever we travel around the world. And then we learn ...
PetHelpful on MSN
Cats Love This Portable and Reversible Catnip-Infused Scratch Pad
Cat scratchers are an excellent way for cats to do what's totally natural to them—scratch. Scratching allows cats to mark ...
Instead of dumping more fuel in to create the extra heat in the catalytic converter to burn off the oxides, Porsche is trying a different approach. The idea is to add more exhaust gas recirculation ...
If you own or are considering buying pharma laggards Pfizer ( PFE +1.42%), Bristol Myers Squibb ( BMY +0.26%), and Merck ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results